$ZSAN On March 4, 2020 , Zosano Pharma Corporation (the "Company") announced that the U.S. Food and Drug Administration (the "FDA") accepted the Company's New Drug Application (the "NDA") for Qtrypta for filing and substantive review. $ZSAN On March 4, 2020 , the Company delivered notice of termination of the Sales Agreement to BTIG because it does not intend to raise additional capital through the ATM, and no additional shares of the Company's common stock will be sold pursuant to the Sales Agreement.
Give Me A Follow If You Want To Consistently Find Winners!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.